Name and surname:
|
RNDr. Michal Konečný, PhD. | |
Email:
|
michal.konecny@ucm.sk | |
Homepage:
|
http:\\ | |
Fakulta/Univerzita:
|
FPV UCM
-
Faculty of Natural Sciences
|
|
Pracovisko:
|
UBB
-
Ústav biológie a biotechnológie
|
III.a - Occupation-position | III.b - Institution | III.c - Duration |
---|---|---|
Laboratory diagnostician, Head of the department | Department of Clinical Genetics, St. Elizabeth Cancer Institute | 2003-2016 |
Professional director | GHC Genetics, Prague | 2017 |
Professional director | Laboratory od Genomics Medicine, GHC GENETICS SK, Bratislava | 2018- |
Professional assistant | Department of Biology, Faculty of Natural Sciences, University of Ss. Cyril and Methodius | 2019- |
IV.a - Activity description, course name, other | IV.b - Name of the institution | IV.c - Year |
---|---|---|
Specialization in the specialized field Laboratory and Diagnostic methods in Clinical Genetics | Slovak Medical University in Bratislava, Limbová 12, 833 03 Bratislava | 2010 |
Specialization in Healthcare Management and Financing | Slovak Medical University in Bratislava, Limbová 12, 833 03 Bratislava | 2017 |
Allocation of scientific qualification level IIa | Slovak Academy of Sciences, Bratislava | 2021 |
Training course for next generation sequencing and applications | Roche, Mannheim, GER | 2013 |
Educational training for sequencing applications on ABI 3130 | Applied Biosystems, Manchester, UK | 2006 |
Member of the working group of the Slovak Ministry of Health for rare diseases | Ministry of Health Slovak Republic | 2010-2012 |
Rare disease workshop | EUCERD, Roma, IT | 2012 |
Rare Diseases Europe Roundtable | EUCERD, Brussels, BEL | 2016 |
Chairman of the professional genetics society | Slovak Society of Medical Genetics, Slovak Medical Society | 2018- |
V.1.a - Name of the profile course | V.1.b - Study programme | V.1.c - Degree | V.1.d - Field of study |
---|---|---|---|
Basic Genomics | Applicated Biology | 1st degree | Applicated Biology, Biotechnology |
Advanced Genomics | Applicated Biology | 2nd degree | Applicated Biology |
New trends, procedures and methods in the study of living organisms | Molecular Biology | 3rd degree | Biotechnology |
Genomics for PhD students | Molecular Biology | 3rd degree | Molecular Biology |
Konecny, M., Kosova, K., Tilandyova, P., ...Markus, J., Ciernikova, S. The results of multigene panel sequencing in Slovak HBOC families. Neoplasma, 2021, 68(3), pp. 652–664
Konecny, M., Markus, J., Waczulikova, I., ...Novosadova, H., Majer, I. The value of SHOX2 methylation test in peripheral blood samples used for the differential diagnosis of lung cancer and other lung disorders. Neoplasma, 2016, 63(2), pp. 246–253.
Konecny, M., Milly, M., Zavodna, K., ...Kausitz, J., Bartosova, Z. Comprehensive genetic characterization of hereditary breast/ovarian cancer families from Slovakia. Breast Cancer Research and Treatment, 2011, 126(1), pp. 119–130.
Konecny, M., Vizvaryova, M., Zavodna, K., ...Kausitz, J., Weismanova, E. Identification of a novel mutations Brca1*c.80 + 3del4 and Brca2*c.6589delA in Slovak HBOC families. Breast Cancer Research and Treatment, 2010, 119(1), pp. 233–237.
Konecny, M., Zavodna, K., Vranova, V., ...Kausitz, J., Bartosova, Z. Identification of rare complete BRCA1 gene deletion using a combination of SNP haplotype analysis, MLPA and array-CGH techniques. Breast Cancer Research and Treatment, 2008, 109(3), pp. 581–583
Konecny, M., Kosova, K., Tilandyova, P., ...Markus, J., Ciernikova, S. The results of multigene panel sequencing in Slovak HBOC families. Neoplasma, 2021, 68(3), pp. 652–664
Zidekova, D., Waczulikova, I., Dolesova, L., ...Lohajova Behulova, R., Konecny, M. Rapid screening test of most frequent BRCA1/BRCA2 pathogenic variants in the NGS era. Neoplasma, 2018, 65(2), pp. 309–315
Jurkovicova, D., Magyerkova, M., Sestakova, Z., ...Kulcsar, L., Chovanec, M. Evaluation of expression profiles of microRNAs and two target genes, FOXO3a and RUNX2, effectively supports diagnostics and therapy predictions in breast cancer. Neoplasma, 2016, 63(6), pp. 941–951.
Konecny, M., Markus, J., Waczulikova, I., ...Novosadova, H., Majer, I. The value of SHOX2 methylation test in peripheral blood samples used for the differential diagnosis of lung cancer and other lung disorders. Neoplasma, 2016, 63(2), pp. 246–253.
Duan, J., Zhong, B., Fan, Z., ...Zhang, X., Sanders, Y.Y. DNA methylation in pulmonary fibrosis and lung cancer. Expert Review of Respiratory Medicine, 2022, 16(5), pp. 519–528
Le, T.-N.N., Tran, V.-K., Nguyen, T.-T., ...Ta, T.-V., Tran, H.-T. BRCA1/2 Mutations in Vietnamese Patients with Hereditary Breast and Ovarian Cancer Syndrome. Genes, 2022, 13(2), 268
Rajabi, F., Mozdarani, H. Expression level of miR-155, miR-15a and miR-19a in peripheral blood of ductal carcinoma breast cancer patients: Possible bioindicators for cellular inherent radiosensitivity. Experimental and Molecular Pathology, 2022, 126, 104758
Wen, S.W.C., Wen, J., Hansen, T.F., Jakobsen, A., Hilberg, O. Cell Free Methylated Tumor DNA in Bronchial Lavage as an Additional Tool for Diagnosing Lung Cancer—A Systematic Review. Cancers, 2022, 14(9), 2254
Yuan, L., Wang, L., Du, X., ...Qin, X., Liu, C. The DNA methylation of FOXO3 and TP53 as a blood biomarker of late-onset asthma. Journal of Translational Medicine, 2020, 18(1), 467
Building a Competence Center for Research and Development in the Field of Molecular Medicine [ITMS 26240220071] - EU ŠF
APVV-20-0070, Sex-specific genetic-endocrine perspective on autism spectrum disorders
President of the Slovak Society of Medical Genetics (SSLG), SMS